2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine

C11H17N5O4S — CID 61130865

IUPAC2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine
SMILESNS(=O)(=O)NCC1CCCN(C(=O)c2c[nH]c(=O)cn2)C1
InChIInChI=1S/C11H17N5O4S/c12-21(19,20)15-4-8-2-1-3-16(7-8)11(18)9-5-14-10(17)6-13-9/h5-6,8,15H,1-4,7H2,(H,14,17)(H2,12,19,20)
InChIKeyZHOBVOLRMIKMLD-UHFFFAOYSA-N
MW315.36 g/mol
LogP-1.58
Rot. Bonds4

About 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine

2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine (PubChem CID 61130865) has the molecular formula C11H17N5O4S and a molecular weight of 315.36 g/mol. Its IUPAC name is 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine.

Molecular Properties

Compound Name2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine
PubChem CID61130865
Molecular FormulaC11H17N5O4S
Molecular Weight315.36 g/mol
Exact Mass315.10
IUPAC Name2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine
SMILESNS(=O)(=O)NCC1CCCN(C(=O)c2c[nH]c(=O)cn2)C1
InChIInChI=1S/C11H17N5O4S/c12-21(19,20)15-4-8-2-1-3-16(7-8)11(18)9-5-14-10(17)6-13-9/h5-6,8,15H,1-4,7H2,(H,14,17)(H2,12,19,20)
InChIKeyZHOBVOLRMIKMLD-UHFFFAOYSA-N
XLogP-1.58
TPSA138.25 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500315.36
LogP ≤ 5-1.58
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[[(3S)-1-(6-oxo-1H-pyrazine-3-carbonyl)piperidin-3-yl]methyl]-1-phenylmethanesulfonamide
CID 97268000
1-(6-oxo-1H-pyrazine-3-carbonyl)piperidine-3-sulfonamide
CID 61128657
5-(3-aminopyrrolidine-1-carbonyl)-1H-pyrazin-2-one
CID 62067809
6-oxo-3-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-4,5-dihydro-1H-pyridazine
CID 60959166
2-methyl-3-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]pyridine
CID 78999103
1-(2-cyclobutylacetyl)-3-[(sulfamoylamino)methyl]piperidine
CID 113244692
phenyl 3-[(sulfamoylamino)methyl]piperidine-1-carboxylate
CID 61132158
1-(4,5-dimethylthiophene-2-carbonyl)-3-[(sulfamoylamino)methyl]piperidine
CID 64722138
1-(4,5-dibromothiophene-2-carbonyl)-3-[(sulfamoylamino)methyl]piperidine
CID 80534447
7-methoxy-3-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]imidazo[1,2-a]pyridine
CID 167788405
1-(2-aminopropanoyl)-3-[(sulfamoylamino)methyl]piperidine
CID 54873272
1-(3-chloro-2-methylpropanoyl)-3-[(sulfamoylamino)methyl]piperidine
CID 62727034

Frequently Asked Questions

What is the IUPAC name of 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine?
The IUPAC name of 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine (CID 61130865) is 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine.
What is the SMILES notation for 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine?
The canonical SMILES for 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine is NS(=O)(=O)NCC1CCCN(C(=O)c2c[nH]c(=O)cn2)C1.
What is the InChIKey of 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine?
The InChIKey is ZHOBVOLRMIKMLD-UHFFFAOYSA-N. The full InChI is InChI=1S/C11H17N5O4S/c12-21(19,20)15-4-8-2-1-3-16(7-8)11(18)9-5-14-10(17)6-13-9/h5-6,8,15H,1-4,7H2,(H,14,17)(H2,12,19,20).
What are the key properties of 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine?
2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine has a molecular weight of 315.36 g/mol, XLogP of -1.58, 4 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-oxo-5-[3-[(sulfamoylamino)methyl]piperidine-1-carbonyl]-1H-pyrazine is sourced from PubChem (CID 61130865), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).